Regulatory Compliance No Trivial Pursuit
Posted on 01-04-2019 by Lisa Thompson

If serious trivia seems like a contradiction, maybe you need to be more quizzical when it comes to anti-corruption compliance. January 4 is the one day of the year when there’s an excuse to be trivial—even in an area as serious as compliance in anti-bribery and corruption , anti-money laundering... Read More

A new No. 1: Petrobras agrees to biggest FCPA settlement
Posted on 10-05-2018 by Lisa Thompson

Petrobras has reached a $1.78 billion settlement with the DOJ and SEC over bribes to politicians and political parties in Brazil. This is the first time an enforcement action over FCPA violations has exceeded a billion dollars. The amount is bigger than the nearest two settlements combined, and the case... Read More

Why Pharma & Biomed Companies’ Risk Analysis Processes are Due for a Check-Up
Posted on 07-18-2018 by Lisa Thompson

Just three years ago, Teva Pharmaceuticals, a drug-maker in Israel, disclosed to both the U.S. Securities & Exchange Commission and the U.S. Department of Justice that an on-going internal probe had revealed possible violations of the Foreign Corrupt Practices Act (FCPA) and/or local laws. Ultimately... Read More

What can companies do to manage bribery and corruption risk better?
Posted on 06-12-2018 by Lisa Thompson

Kathryn Higgs is Director of Transparency International’s Business Integrity Program. Prior to that she was head of ethics and compliance at Tesco and chief compliance officer at Balfour Beatty. In an exclusive interview with LexisNexis, she says that technology has increased the risk of bribery... Read More